You are here: Industry Insights > Merck

News List

Gardasil posts big Q1 beat to push Merck vaccines to 21% growth fiercepharma
May 03, 2017
Merck’s vaccines powered ahead to start the year, helping the drug giant offset other areas of weakness on the way to slight growth overall. Led by HPV vaccine franchise Gardasil and pneumococcal shot Pneumovax 23, Merck’s vaccine sales grew 21% in the fi
Financial Report: Merck contractpharma
May 03, 2017
Pharmaceutical sales were up 1% to $8.2 billion, driven by oncology, hepatitis C and vaccines, largely offset by the loss of market exclusivity for ZETIA, CUBICIN, and NASONEX。。。
Merck divests Biosimilars business to Fresenius worldpharmanews
April 26, 2017
Merck, a leading science and technology company, has announced the divestment of its Biosimilars business to Fresenius.
Merck sells biosimilars business to Fresenius pharmatimes
April 26, 2017
Merck has divested its biosimilars business to fellow German drugmaker Fresenius in a deal potentially worth 670 million euros.
Merck Donates $300,000 to Support Neglected Tropical Disease Elimination Efforts in Africa americanpharmaceuticalreview
April 24, 2017
Merck Donates $300,000 to Support Neglected Tropical Disease Elimination Efforts in Africa
BioInvent expands manufacturing facility with Mobius bioreactors from Merck cphi-online
April 24, 2017
Fully scalable system streamlines drug development and production.
Merck Announces New Phase 2 Data on Investigational Triple Combination Therapy MK-3682B for Chronic firstwordpharma
April 24, 2017
indings Presented at The International Liver Congress™ 2017 Show High Rates of Sustained Virologic Response (SVR12) in Genotype 1 Patients for Whom Direct-Acting Antiviral Therapy Had Previously Failed
Atara Bio, Merck in Clinical Combo Alliance contractpharma
April 24, 2017
Atara to evaluate its ATA129 with Merck’s Keytruda
Merck Receives 2017 ENERGY STAR Sustained Excellence Award from EPA americanpharmaceuticalreview
April 10, 2017
Merck has received an ENERGY STAR 2017 Partner of the Year – Sustained Excellence Award from the U.S. Environmental Protection Agency (EPA) for its continued improvement of energy performance and leadership in energy management in both the pharmaceutical
Merck receives CRL from the FDA for TECOS study with sitagliptin cphi-online
April 10, 2017
CRL relates to Merck's sNDA for Januvia, Janumet and Janumet XR.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page